Role of piracetam on cognitive function in epilepsy and with antiepileptics in rats

Siddharth R. Chaudhari, Priti P. Dhande, Vijaya A. Pandit

Abstract


Background: To study extent of cognitive impairment by epilepsy & antiepileptic treatment and evaluate the role of piracetam on it.

Methods: 48 animals were divided into 6 groups: I-Control, II- Topiramate, III-Topiramate+Piracetam, IV-Valproate, V-Valproate+Piracetam, VI-Piracetam. Baseline cognitive functions were measured using Cook’s pole climbing apparatus (CPCA) and Elevated plus maze (EPM). In CPCA, on completion of training, number of avoidances (NOA) out of 10 trials were noted while in EPM, transfer latency (TL) was measured. Kindling was induced by 30mg/kg Pentylenetetrazol (PTZ), i.p. to all groups (except Group I) on alternate days till seizures developed. Groups were treated with respective drugs orally for 21 days and cognitive functions measured again.

Results: Significant decrease in NOA & increase in TL was observed after PTZ kindling. Topiramate further significantly impaired NOA and TL whereas Valproate significantly reduced NOA in CPCA but increase in TL was not significant. Treatment with Piracetam significantly increased Topiramate, Valproate and PTZ kindling induced decrease in NOA as also significantly reduced Topiramate and PTZ kindling induced increase in TL.

Conclusion: Seizures are associated with cognitive impairment. Cognitive impairment caused by Sodium valproate differs from Topiramate. Piracetam, a known nootropic can be used in alleviating cognitive impairment associated with epilepsy & chronic antiepileptic therapy.


Keywords


Cognition, Pentylenetetrazol, Kindling, Topiramate, Valproate, Piracetam

Full Text:

PDF

References


Motamedi G, Meador K. Epilepsy and cognition. Epilepsy Behav 2003 Oct;4(2):25-38.

Hermann B, Seidenberg M. Epilepsy and cognition. Epilepsy Curr 2007 Jan-Feb;7(1):1-6.

Nicholson CD. Pharmacology of nootropics and metabolically active compounds in relation to their use in dementia. Psychopharmacology 1990; 101(2): 147-59.

Shahid M, Pillai KK, Vohora D. Reversal of phenytoin-induced impairment of spontaneous alternation by piracetam in mice: Involvement of cholinergic system. Indian J Pharmacol 2004;36:

-4.

Cook L, Weidley E. Behavioral effects of some psychopharmacological agents. Ann N Y Acad Sci 1957;66(3):740-52.

Soman I, Mengi SA, Kasture SB. Effect of leaves of Butea frondosa on stress, anxiety, and cognition in rats. Pharmacol Biochem Behav 2004;79(1):11-6.

Saito H, Tsuchiya M, Naka S, Takagi K. Effects of Panax Ginseng root on conditioned avoidance response in rats. Jpn J Pharmacol 1977;27(4):509-16.

Walf AA, Frye CA. The use of the elevated plus maze as an assay of anxiety-related behavior in rodents. Nat Protoc 2007;2(2):322-8.

Itoh J, Nabeshima T, Kameyama T. Utility of an elevated plus-maze for the evaluation of memory in mice: effects of nootropics, scopolamine and electroconvulsive shock. Psychopharmacology 1990;101(1):27-33.

Mehla J, Reeta KH, Gupta P, Gupta YK. Protective effect of curcumin against seizures and cognitive impairment in a Pentylenetetrazol-kindled epileptic rat model. Life Sci 2010 Nov 20;87(19-22):596-603.

Pohle W, Becker A, Grecksch G, Juhre A, Willenberg A. Piracetam prevents Pentylenetetrazol kindling-induced neuronal loss and learning deficits. Seizure 1997;6(6):467-74.

Ruethrich H, Grecksch G, Becker A, Krug M. Potentiation effects in the dentate gyrus of Pentylenetetrazol-kindled rats. Physiol Behav 1996; 60(2):455-62.

Rauca C, Zerbe R, Jantze H. Formation of free hydroxyl radicals after Pentylenetetrazol-induced seizure and kindling. Brain Res 1999;847(2):347-51.

Gilman SC, Bonner MJ, Pellmar TC. Free radicals enhance basal release of D-[3H]aspartate from cerebral cortical synaptosomes. J Neurochem 1994; 62(5):1757-63.

Nyback H, Wiesel FA, Skett P. Effects of piracetam on brain monoamine metabolism and serum prolactin levels in the rat. Psychopharmacology 1979;61(3):235-8.

Wurtman RJ, Magil SG, Reinstein DK. Piracetam diminishes hippocampal acetylcholine levels in rats. Life Sci 1981; 28(10):1091-3.

Bering B, Müller WE. Interaction of piracetam with several neurotransmitter receptors in the central nervous system. Relative specificity for 3H-glutamate sites. Arzneimittelforschung 1985;35(2): 1350-2.

Hitzenberger G, Rameis H, Manigley C. Pharmacological Properties of Piracetam. Rationale for Use in Stroke Patients. CNS Drugs 1998; 9 (Suppl. 1):19-27.

Carreño M, Donaire A, Sánchez-Carpintero R. Cognitive disorders associated with epilepsy: diagnosis and treatment. Neurologist 2008;14

(6 Suppl 1):S26-34.

Blum D, Meador K, Biton V, Fakhoury T, Shneker B, Chung S, et al. Cognitive effects of lamotrigine compared with topiramate in patients with epilepsy. Neurology 2006;67(3):400-6.

Agarwal NB, Agarwal NK, Mediratta PK, Sharma KK. Effect of lamotrigine, oxcarbazepine and topiramate on cognitive functions and oxidative stress in PTZ-kindled mice. Seizure 2011; 20(3): 257-62.

Pavone A, Cardile V. An in vitro study of new antiepileptic drugs and astrocytes. Epilepsia 2003;44 (Suppl 10):34-9.

Fraser CM, Sills GJ, Forrest G, Thompson GG, Brodie MJ. Effects of anti-epileptic drugs on glutamine synthetase activity in mouse brain. Br J Pharmacol 1999;126(7):1634-8.

Higgins GA, Breysse N, Undzys E, Derksen DR, Jeffrey M, Scott BW, et al. Comparative study of five antiepileptic drugs on a translational cognitive measure in the rat: relationship to antiepileptic property. Psychopharmacology 2010;207(4):513-27.

Kwan P, Brodie MJ. Neuropsychological effects of epilepsy and antiepileptic drugs. Lancet 2001 Jan; 357: 216-22.

Aldenkamp AP, Baker G, Mulder OG, Chadwick D, Cooper P, Doelman J, et al. A multicenter, randomized clinical study to evaluate the effect on cognitive function of topiramate compared with valproate as add-on therapy to carbamazepine in patients with partial-onset seizures. Epilepsia 2000; 41(9):1167-78.

Meador KJ, Loring DW, Hulihan JF, Kamin M, Karim R. Differential cognitive and behavioral effects of topiramate and valproate. Neurology 2003; 60(9):1483-8.

Umka J, Mustafa S, ElBeltagy M, Thorpe A, Latif L, Bennett G, et al. Valproic acid reduces spatial working memory and cell proliferation in the hippocampus. Neuroscience 2010; 166(1):15-22.

Sansone M, Oliverio A. Avoidance facilitation by nootropics. Prog Neuropsychopharmacol Biol Psychiatry 1989;13:S89-97.

Keil U, Scherping I, Hauptmann S, Schuessel K, Eckert A, Müller WE. Piracetam improves mitochondrial dysfunction following oxidative stress. Br J Pharmacol 2006;147(2):199-208.